An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

Clinical trial NCT07223372 · RECRUITING

Trial details

NCT number: NCT07223372
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Hormonesensitive Prostate Cancer (mHSPC)

Start date: 2025-10-10
Primary completion: 2026-11-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.